Results 141 to 150 of about 1,335,871 (234)

Flavones and Aminoflavones Increase the Cytotoxicity of NK Cells in Human Non-Small Cell Lung Cancer. [PDF]

J Cell Mol Med
Hsu PC, Chien CC, Cheng YJ, Chang CH, Shih TL.   +4 more
europepmc   +1 more source

An evolving landscape: predictive and therapeutic biomarkers in advanced non-small cell lung cancer. [PDF]

Front Oncol
Fortman D, Qin A.
europepmc   +1 more source

Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancer. [PDF]

EBioMedicine
Lee P, Abdelhamid K, Butler R, Cooper W, Nagasaka M, Peters S, Seijo L, Silvestri G, Wee B, Yasufuku K, Navani N.   +10 more
europepmc   +1 more source

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Journal of Clinical Oncology, 2004
N. Hanna, F. Shepherd, F. Fossella, J. R. Pereira, F. de Marinis, J. von Pawel, U. Gatzemeier, T. Tsao, M. Pless, T. Muller, H. Lim, C. Desch, K. Szondy, R. Gervais, Shaharyar, C. Manegold, S. Paul, P. Paoletti, L. Einhorn, P. Bunn   +19 more
semanticscholar   +1 more source

Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer. [PDF]

Front Immunol
Guo H, Xu Z, Li K, Guo C, Lin F, Pu Q, Wang G.   +6 more
europepmc   +1 more source

The relationship between genetic mutations and organ metastasis in non-small cell lung cancer. [PDF]

Ther Adv Med Oncol
Xue H, Chen Y, Qi F, Chen K, Liu X, Zhang M, Gao Z, Cai S, Gao T, Zhang T.   +9 more
europepmc   +1 more source

Lung: Non-Small Cell Lung Cancer

Annals of Oncology, 1996
openaire   +1 more source

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Journal of the American Medical Association (JAMA), 2003
M. Kris, R. Natale, R. Herbst, T. Lynch, D. Prager, C. Belani, J. Schiller, K. Kelly, H. Spiridonidis, A. Sandler, K. Albain, D. Cella, M. Wolf, S. Averbuch, J. Ochs, A. Kay   +15 more
semanticscholar   +1 more source

Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD Study. [PDF]

Oncol Res
Cheng S, Kordbacheh T, Banyard A, Chaturvedi A, Sanchez Martinez D, Hiley CT, Harris M, Chan C, Faivre-Finn C, Illidge TM, Cheadle EJ.   +10 more
europepmc   +1 more source

Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer.

Journal of Thoracic Disease, 2018
P. Tomasini, L. Greillier, Arnaud Boyer, Arnaud Jeanson, F. Barlesi   +4 more
semanticscholar   +1 more source